Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 868.26 million compared to CNY 721.89 million a year ago. Net income was CNY 192.99 million compared to CNY 150.8 million a year ago.

Basic earnings per share from continuing operations was CNY 0.78 compared to CNY 0.85 a year ago.